Contact us
Innovation
Company
Therapeutic areas
Investors
News
Career
Contact
Verigraft
Arvid Wallgrens Backe 20
41346 Gothenburg
Sweden
info@verigraft.com
Home
/
News
/
VERIGRAFT was selected as a finalist…
News
Published: April 8, 2021
VERIGRAFT was selected as a finalist in the 2021 Lyfebulb-CSL Behring Innovation Challenge
Lyfebulb Challenge
Latest news
See all news
News
Published: October 2, 2023
Recently published article about VERIGRAFT in MedTech Insight
Event
Published: September 26, 2023
VERIGRAFT AB to Present at 2023 Cell & Gene Meeting on the Mesa
News
Published: September 19, 2023
Study update: One third of the patients recruited in TECVI-1
Published: July 11, 2023
New Scientific Publication on VERIGRAFT P-TEV
Event
Published: June 13, 2023
VERIGRAFT is running for blood donation
Published: June 8, 2023
VERIGRAFT supports major investment in national center for Advanced Therapies